![]() | ![]() |
Formats:
|
||||||||||||||||||||
Copyright © 2007, European Molecular Biology Organization AP endonuclease paralogues with distinct activities in DNA repair and bacterial pathogenesis 1Centre for Structural Biology, Division of Molecular Biosciences, Faculty of Natural Sciences 2Centre for Molecular Microbiology and Infection, Department of Infectious Diseases, Faculty of Medicine, Imperial College London, London, UK aDepartment of Infectious Diseases, Faculty of Medicine, Centre for Molecular Microbiology and Infection, Imperial College London, London SW7 2AZ, UK. Tel.: +44 207 594 3072; E-mail: c.tang/at/imperial.ac.uk bDivision of Molecular Biosciences, Faculty of Natural Sciences, Centre for Structural Biology, Imperial College London, London SW7 2AZ, UK. Tel.: +44 207 594 5288; E-mail: g.baldwin/at/imperial.ac.uk cDivision of Molecular Biosciences, Faculty of Natural Sciences, Centre for Structural Biology, Imperial College London, London SW7 2AZ, UK. Tel.: +44 207 594 3086; Fax: +44 207 594 3057; E-mail: p.freemont/at/imperial.ac.uk *These authors contributed equally to this work †Present address: Structural Biology Group, Randall Division of Cell and Molecular Biophysics, King's College London, London ‡Present address: Department of Informatics, Aristotle University of Thessaloniki, Thesssaloniki 54124, Greece Received September 29, 2006; Accepted December 21, 2006. This article has been cited by other articles in PMC.Abstract Oxidative stress is a principal cause of DNA damage, and mechanisms to repair this damage are among the most highly conserved of biological processes. Oxidative stress is also used by phagocytes to attack bacterial pathogens in defence of the host. We have identified and characterised two apurinic/apyrimidinic (AP) endonuclease paralogues in the human pathogen Neisseria meningitidis. The presence of multiple versions of DNA repair enzymes in a single organism is usually thought to reflect redundancy in activities that are essential for cellular viability. We demonstrate here that these two AP endonuclease paralogues have distinct activities in DNA repair: one is a typical Neisserial AP endonuclease (NApe), whereas the other is a specialised 3′-phosphodiesterase Neisserial exonuclease (NExo). The lack of AP endonuclease activity of NExo is shown to be attributable to the presence of a histidine side chain, blocking the abasic ribose-binding site. Both enzymes are necessary for survival of N. meningitidis under oxidative stress and during bloodstream infection. The novel functional pairing of NExo and NApe is widespread among bacteria and appears to have evolved independently on several occasions. Keywords: DNA repair, exonuclease, Neisseria meningitidis, repair phosphodiesterase, X-ray structure Introduction DNA repair is one of the most highly conserved biological processes and is fundamental to the survival of all free-living organisms. One of the principal causes of DNA damage is oxidative stress (Lindahl, 1993), and base excision repair (BER) is the primary mechanism used to counter the genotoxic effects of oxidation. Apurinic/apyrimidinic (AP) endonucleases are central to BER (Lindahl, 1993; Bjelland and Seeberg, 2003). These enzymes excise abasic residues from the DNA backbone that arise spontaneously (through depurination or depyrimidination) or by the action of DNA glycosylases (which recognise and remove bases damaged by oxidation). AP endonucleases bind abasic residues and cleave the DNA 5′ to the abasic site, leaving a 3′-hydroxyl, which is then repaired by DNA polymerases (Demple and Harrison, 1994; Dianov et al, 2003). Many organisms possess two functional AP endonucleases. For example, Escherichia coli expresses ExoIII and EndoIV, representatives of the structurally distinct Xth and Nfo AP endonuclease families, respectively (Ljungquist et al, 1976). Humans and Saccharomyces cerevisiae also have two functional AP endonucleases. S. cerevisiae has the same complement of enzymes as E. coli, but the major enzyme is from the Nfo family (Boiteux and Guillet, 2004), whereas the human AP endonucleases, HAP1 and HAP2, are both members of the Xth family (Hadi and Wilson, 2000); HAP1 is the major human AP endonuclease with an essential function in higher eukaryotes (Xanthoudakis et al, 1996; Ludwig et al, 1998; Meira et al, 2001; Demple and Sung, 2005; Izumi et al, 2005). The duplication of AP endonuclease activity is thought to reflect the fundamental importance of their role in cellular viability. DNA repair is also vital for the survival and propagation of bacterial pathogens. Bacteria undergo frequent replication, providing the opportunity for rapid accumulation of potentially cytotoxic mutations. Bacteria are also subject to oxidative stress during pathogenesis and must overcome the devastating damage caused by the oxidative burst within phagocytic cells of the immune system. To date, there have been few studies that have examined the role of BER during pathogenesis despite its importance in maintenance of DNA integrity in the face of the innate host response to infection. Salmonella typhimurium requires its full complement of DNA glycosylases to survive effectively within host macrophages, and the putative AP endonuclease in Brucella abortus is necessary for the pathogen to resist oxidative stress (Suvarnapunya and Stein, 2005; Hornback and Roop, 2006). However, in neither instance was the biochemical activity of the gene product determined; the studies relied upon the characterisation of strains lacking genes identified by sequence comparison alone. Neisseria meningitidis is a Gram-negative bacterium, which is a causative agent of meningitis and septicaemia in humans. This pathogen is closely associated with the human host and undergoes a wide range of interactions with host cells. During progression of disease, N. meningitidis is internalised by phagocytic cells of the immune system and is subjected to the oxidative burst. The importance of meningococcal genome dynamics has been recognised, and several genes encoding putative BER enzymes have been identified by bioinformatic analysis (Davidsen and Tonjum, 2006). However, only MutY, a DNA glycosylase, has been characterised at a biochemical level, although its role during pathogenesis has not been examined (Davidsen et al, 2005). In this work, we identify two AP endonuclease paralogues within the meningococcal genome. Structural and biochemical characterisation of the products of these genes reveals these BER enzymes, Neisserial exonuclease (NExo) and Neisserial AP endonuclease (NApe), have distinct activities, and are both necessary for resistance to oxidative stress and for meningococcal virulence. Results Characterisation of NExo, an AP endonuclease paralogue A search for homologues of E. coli ExoIII in the trEMBL database identified a N. meningitidis gene, NMB0399, whose predicted product shares 34% amino-acid identity with ExoIII (Supplementary Table S1). We examined the activity of recombinant NMB0399 against two 25 bp double-stranded DNA substrates. The first (25U) contains a uracil 11 bases from the 5′ end, whereas the second (25AP) is 25U after treatment with uracil DNA glycosylase (UDG) to generate an abasic site at the position previously occupied by the uracil. With 25U, NMB0399 exhibited 3′-5′ exonuclease activity, similar to known AP endonucleases, although at a significantly lower rate than ExoIII (Figure 1A
We next examined whether NExo had 3′-deoxyribose phosphodiesterase (3′-dRpase) activity as this can also be catalysed by AP endonucleases. 3′-dRpases process 3′-blocked ends that are produced by single-strand breaks following oxidative damage (Takemoto et al, 1998; Dahm-Daphi et al, 2000) or by DNA glycosylases with lyase activity, which cleave abasic sites leaving a 3′-unsaturated aldehyde or phosphate (Michaels and Miller, 1992; Demple and Harrison, 1994; Agnez et al, 1996). Failure to remove these blocking residues is detrimental to cellular survival (Izumi et al, 1992; Takemoto et al, 1998; Boiteux and Guillet, 2004). Interestingly, NExo is a highly efficient 3′-dRpase. This was demonstrated experimentally using a nicked substrate with a 3′-dRp (50N), which was generated by reacting a 50 bp DNA duplex with a U at position 21 (50U) with UDG and the E. coli AP lyase endonuclease III. Incubating NExo with the 50N substrate resulted in the efficient removal of the 3′-dRp, leaving a 3′-OH (Figure 1B A single amino-acid substitution can restore AP endonuclease activity on NExo To investigate the molecular basis of these unique properties of NExo, we solved the NExo crystal structure at a 1.9 Å resolution, and found that it displays the characteristic four-layered α/β sandwich structure common to ExoIII and HAP1 (Mol et al, 1995; Gorman et al, 1997) (Figure 2A
To test this possibility, we mutated NExo His167 to a Gly or a Ser, the corresponding residues in HAP1 and ExoIII, respectively. The modified enzymes retained exonuclease activity at similar levels to wild-type NExo (Figure 3C Identification of the functional N. meningitidis AP endonuclease As NExo had no apparent AP endonuclease activity, we searched the N. meningitidis genome for further AP endonuclease paralogues using the HAP1 sequence and identified NMB2082 (Supplementary Figure S2). The crystal structure of NMB2082 was solved at a 1.5 Å resolution and showed a high degree of structural similarity with NExo, HAP1 and ExoIII (rmsd <1.7 Å over 210 Cαs; Figure 2A
NExo and NApe are necessary for resistance to oxidative stress Oxidative stress is an important aspect of innate immunity against bacterial pathogens, and AP endonucleases are critical for repairing DNA lesions induced by oxidative stress. Therefore, we examined the role of NApe and NExo in bacterial survival under oxidative stress. We first confirmed by Western blot that NExo and NApe are expressed by N. meningitidis (Figure 5A
NExo and NApe are necessary for virulence The generation of oxidative stress is an important aspect of defence against microbial infection in vivo. Therefore, we evaluated the physiological relevance of the sensitivity to oxidative stress of the NExo and NApe mutant strains by assessing their ability to cause bacteraemia, an essential step during the pathogenesis of meningococcal infection. We initially determined that the mutations do not attenuate normal growth of the bacterium by performing growth curves (Supplementary Figure S3). The mutants were recovered from the bloodstream of infected infant rats at significantly lower levels than the wild-type strain, demonstrating that both NApe and NExo are required for full virulence (Figure 6
The NExo/NApe pairing occurs frequently among bacterial species Duplication of AP endonuclease enzymes as seen in numerous organisms may result from the critical nature of the BER pathway for cellular viability. However, our structure–function characterisation of AP endonuclease paralogues in the meningococcus demonstrates that there is specialisation in the activity of these enzymes. We considered whether having enzymes with distinct functions (such as NExo and NApe) could be unique to N. meningitidis, because, unlike most bacteria, it lacks an SOS response (Morelle et al, 2005) and thus might employ atypical mechanisms for dealing with DNA damage. Therefore, we analysed complete bacterial genome sequences for NExo and NApe homologues, paying particular attention to the nature of the amino acid at the residue equivalent to NExo His167. We identified a wide range of bacteria that contain a NExo/NApe pairing (Figure 7
Discussion Functional variation within AP endonucleases The Xth family of AP endonucleases are well conserved at the structural level, with a four-layered αβ-sandwich structure. The enzymes in this family are able to perform a wide variety of excision and incision reactions on DNA substrates, including AP endonuclease, 3′-5′ exonuclease, 3′-dRpase and 3′-phosphatase, and occasionally nonspecific DNase activities (Weston et al, 1992; Miertzschke and Greiner-Stoffele, 2003). The class II AP endonucleases typically perform the first three or four of these reactions. In contrast to DNaseI, these enzymes have additional surface loops that interact with the DNA and are required for abasic site recognition (Gorman et al, 1997; Cal et al, 1998; Mol et al, 2000). Both NExo and NApe possess the surface loops expected in an AP endonuclease enzyme, but with variations in sequence. Structural analysis has revealed that a determinant of NExo activity is a His residue, which blocks the position where the flipped-out abasic ribose would bind in an AP endonuclease. For DNA to bind to an AP endonuclease, the abasic ribose must first be everted from the DNA helix and the DNA bent by approximately 35° (Gorman et al, 1997; Mol et al, 2000). His167 would prevent NExo from flipping out the abasic ribose. Mutation of this residue to a smaller residue, opening up the abasic ribose-binding site, conferred AP endonuclease activity on NExo and clearly demonstrates the importance of this residue in defining enzyme activity. The region immediately before His167 in NExo forms a loop, which may interact with DNA. The equivalent of His167 in NExo in the nonspecific endonuclease DNAse1 is Tyr175. It has been shown that insertion of the helical sequence from ExoIII immediately before Tyr175 confers AP endonuclease activity onto DNase1 (Cal et al, 1998). As there is no structure for DNase1 with this insertion, it is unclear whether the recovery of AP endonuclease activity is because of the presence of the helix, or movement of the Tyr175 side chain, resulting in creation of an abasic ribose-binding site. We predict that both the abasic ribose-binding site blocking residues and the DNA-binding loops will determine the balance of AP endonuclease, 3′-dRpase and exonuclease activities found in individual enzymes. It is now becoming apparent that different AP endonuclease enzymes have different efficiencies by which they catalyse the different reactions, and this most likely reflects their in vivo function. For instance, E. coli ExoIII is an active AP endonuclease and also a strong 3′-5′ exonuclease and 3′-dRpase, whereas the human AP endonuclease HAP1 is a very efficient AP endonuclease, but a poor 3′-5′ exonuclease and 3′-dRpase (Wilson et al, 1995; Suh et al, 1997). In contrast, the second human AP endonuclease HAP2 has low AP endonuclease activity, but strong 3′-5′ exonuclease and 3′-dRpase activities (Burkovics et al, 2006). NExo is a very active 3′-dRpase, but a weak 3′-5′ exonuclease and lacks detectable AP activity. Our characterisation of NExo thus represents the first description of an enzyme, which by both sequence and structure closely resembles other class II AP endonucleases of the Xth family, yet has no discernable AP activity. NExo appears to be a highly specialised 3'-dRpase. We consider this specialisation to be indicative of the importance of removing 3'-blocking lesions, which probably contribute more to cell lethality than abasic DNA sites (Izumi et al, 1992; Takemoto et al, 1998; Boiteux and Guillet, 2004). Although abasic sites are mutagenic, they may be bypassed by DNA polymerases, whereas blocks to replication are more detrimental. In vivo function of NExo and NApe The distinct enzyme activities of NExo and NApe suggest that they have evolved to perform different functions within the cell. In vivo assays demonstrate this to be the case, as the effects of the individual mutations are additive in the double mutant. This is true both for survival assays in the face of oxidative stress, and in infectivity assays. NExo and NApe therefore operate in discrete pathways, although they possess overlapping activity. This may be owing to differences in substrate specificity for the two enzymes: a number of different 3′-blocking lesions can arise through oxidative or other damage processes in addition to the 3′-dRp that we have tested, including 3′-glycolate and 3′-phosphate. Alternatively, AP endonucleases can interact with some DNA glycosylases to facilitate DNA repair through a hand-over process that protects mutagenic intermediates in the repair pathway (Waters et al, 1999; Hosfield et al, 2001). The functionality of NExo and NApe may therefore be due to the separation of discrete DNA repair pathways through interactions of protein networks. Implications for bacterial pathogenesis To survive periods of sustained high levels of DNA damage, many bacterial pathogens possess an SOS response. This damage-inducible system is characterised by a general upregulation of a range of components of DNA repair pathways following detection of DNA damage. The SOS response has been well studied in a number of pathogenic and non-pathogenic bacterial species, including E. coli, Staphylococcus aureus, Vibrio cholerae and Bacillus subtilis (Wojciechowski et al, 1991; Michel, 2005; Goerke et al, 2006; Quinones et al, 2006). Interestingly, N. meningitidis does not possess an SOS response, and is thus thought to be unable to upregulate expression of components of the repair pathway. Comparison of the expression of NExo and NApe in the presence and absence of oxidative agents confirms that there is no change in the production of the two enzymes when the bacterium is exposed to oxidative stress (data not shown). Therefore, the lack of upregulation of NExo and NApe production is entirely consistent with the absence of an SOS response. The mechanisms by which pathogenic Neisseria neutralise exposure to oxidising agents have been studied extensively. In the gonococcus, these include the production of superoxide dismutases (Sods), catalase and peroxidase (Seib et al, 2004). In N. meningitidis, Sod is required to evade internalisation by phagocytic cells and provides protection against the action of reactive oxygen species (Dunn et al, 2003; Seib et al, 2004). Production of both glutathione peroxidase and catalase aid resistance to paraquat and hydrogen peroxide, respectively (Moore and Sparling, 1996; Seib et al, 2004). Despite the presence of these protective systems, our results clearly show that the ability to repair oxidative DNA damage still contributes significantly to the survival of the bacterium under oxidative stress. Furthermore, these repair enzymes are necessary for wild-type levels of virulence. The attenuation of the mutant strains lacking NExo and NApe is likely to be because of their inability to prevent accumulation of deleterious mutations arising as a result of stress induced by products of the host cellular metabolism or phagocyte oxidative burst. Diversity and evolution Diverse bacteria have evolved to contain a NExo/NApe pairing, defining a novel combination of structurally related, but functionally distinct enzymes in BER. Characterisation of the NApe and NExo knockout strains demonstrates that their functions appear to be independent. The widespread distribution of NApe paralogues among bacteria (including those with a saprophytic lifestyle) indicates that they were unlikely to have been acquired recently by horizontal transfer from a eukaryotic host. Instead, the pairing of NApe and NExo appears to have arisen on several occasions in distinct prokaryotic lineages, indicating that it must provide a significant evolutionary advantage to certain microbes. Conclusion We have characterised two Xth family members from N. meningitidis, which have distinct activities in DNA repair. This specialisation of enzyme function within the BER pathway, which is distinct from the redundancy observed in other organisms, is a novel paradigm present in a wide variety of bacteria that is relevant to the infectivity of human pathogens such as N. meningitidis. Materials and methods Bacterial strains and growth N. meningitidis was grown on BHI media with 5% Levanthal's supplement, and incubated at 37°C in the presence of 5% CO2. E. coli XL1-blue cells (Invitrogen, for recombinant work) and ER2566 (New England Biolabs), for protein expression, were propagated in LB media. Antibiotics were used at the following final concentrations: ampicillin, 100 μg/ml; kanamycin, 75 μg/ml; and tetracycline, 2 μg/ml. Identification and site-directed mutagenesis of NExo and NApe NMB0399 was identified as a possible AP endonuclease paralogue by searching the trEMBL database (Boeckmann et al, 2003) using the programme BLAST (Altschul et al, 1997), implemented at the European Bioinformatics Institute (www.ebi.ac.uk). NMB2082 was identified by searching the serogroup B N. meningitidis genome, with the HAP1 gene, using the Sanger Institute's version of the programme BLAST. NMB0399 and NMB2082 were amplified by PCR from N. meningitidis with the primers NMB0399A and NMB0399B for NMB0399, and primers NMB2082A and NMB2082B for NMB2082 (Supplementary Table S3). Relevant restriction sites are underlined. PCR products were digested with BamHI and HindIII, cloned into pProEX HTb (Invitrogen) and transformed into E. coli XL1-Blue (Invitrogen). Subsequently, plasmids were transformed into E. coli ER2566 for protein expression. The mutants, NExoD146N, NExoH167S and NExoH167G, were obtained using the Stratagene QuikChange Site-Directed Mutagenesis kit with primers D146Nf and D146Nr for NExoD146N; and H167Sf and H167Sr for NExoH167S; H167Gf and H167Gr for NExoH167G (Supplementary Table S3). All mutations were verified by DNA sequencing. Protein expression and purification E. coli cultures of 3–6 l were grown to an OD A600 of 0.4–0.6 in LB medium and protein expression was induced by the addition of 1 mM IPTG, followed by continued growth for 3 h at 37°C. Cells were harvested by centrifugation. Pellets were resuspended in buffer containing 25 mM Tris (pH 8.0), 25 mM imidazole, and 0.5 M NaCl (buffer A), and lysed by pulse sonication. The lysate was cleared by centrifugation. His-tagged proteins were purified using a metal-affinity HisTrap chelating HP column (GE Healthcare) pre-equilibrated with CoCl2. Proteins were eluted with an imidazole gradient and dialysed into buffer containing 50 mM Tris (pH 8), 0.5 mM EDTA, and 1.0 mM DTT. The His tag was cleaved by the addition of TEV protease (Invitrogen) and the sample was then dialysed against buffer A. The cleaved proteins were applied to a cobalt-loaded HisTrap column and the protein of interest was found in the flow-through. NApe was further purified by size-exclusion chromatography using HiLoad 16/60 Superdex 200 prep grade column (GE Healthcare) pre-equilibrated in 10 mM Tris (pH 7.0), 100 mM NaCl. NExo samples were crystallised without prior size exclusion chromatography. Biochemical assays Double-stranded DNA substrates 25U, 50U and 71AP were made by mixing equimolar amounts of complementary strands, heating to 90°C and cooling slowly to room temperature. One strand contained a uracil residue and a 5′-hexachlorofluorescein residue (HEX) for visualisation; the complementary strand was unmodified. The sequence of the double-stranded 25U oligonucleotide was 5′-HEXGGATCACTATUATAGGTAGTTTAT–3′; the sequence of the double-stranded 50U oligonucleotide was 5′-HEXCGTGTATGACATCTAACTATUATAGCGCT CATCGTCATCGTCATCCTCGGCACCGT-3′ (U was paired with A in both cases). The double-stranded 71AP substrate contained an abasic furanose analogue at position 36, the sequence was 5′-(HEX)-GAG CAG AGT CAG TGC TGC TAC GAG CGG ATC ACT ATF ATA GGT AGT TTA TCC TAC GAA CTC CGT CCG TAC CG-3′, where F is the abasic furanose analogue. Oligonucleotides were synthesised and HPLC-purified by MWG Biotech (Ebersberg, Germany) or Eurogentec (71AP). The 25U and 50U substrates were reacted with 100 nM Herpes simplex virus type-1 uracil DNA glycosylase (UDG) for 2 h at 25°C to create the abasic 25AP and 50AP DNAs (Bellamy and Baldwin, 2001). Nicked DNA was produced by reacting 200 nM of 50AP DNA with 25 U of endonuclease III (New England Biolabs) in standard reaction buffer (20 mM Tris pH 7.5, 1 mM EDTA, 20 mM NaCl, and 0.1 mg/ml BSA) at 37°C for 90 min. Nuclease assays were performed in a standard reaction buffer supplemented with 15 mM MgCl2 at 25°C. Aliquots were removed at specified time points as detailed in the figure legends, and quenched in formamide loading buffer (0.01% xylene cyanol, 0.01% bromophenol blue, 30 mM EDTA in formamide) before separation via denaturing polyacrylamide gel electrophoresis. All assays used 100 nM of the respective DNA substrate and an equivalent of 500 fmol of DNA substrate per lane was loaded onto acrylamide gels. Enzyme concentrations vary as described in the figure legends. Exonuclease assays were analysed using 15% PAGE, whereas end-processing assays used 20% PAGE. Data were fitted using Grafit 5 (Erithacus software). Crystallization and X-ray crystallography NExo was dialysed into 10 mM Tris, pH 7.0, 100 mM NaCl and concentrated to 9 mg/ml before crystallisation. Crystals were obtained in 96-well Corning plates using 1 μl of protein and 1 μl of well solution. The well solution consisted of 0.1 M sodium cacodylate, pH 6.5, 0.2 M sodium acetate and 15% PEG 8000. Crystals were transferred into a cryobuffer containing all the well-solution components and 25% PEG400. Data were collected to 1.9 Å on beamline 14.1 at the SRS synchrotron in Daresbury, UK (see Table I).
The NApe crystals were obtained from hanging-drop experiments using 24-well Linbro plates with drops of 0.5 μl protein (20 mg/ml) in 10 mM Tris, pH 7.0 and 100 mM NaCl, and 0.5 μl well solution at 20°C. The well solution contained 20% PEG 20000, 0.1 M bicine, pH 9.0 and 2% dioxane. NApe crystals were placed in a cryobuffer with 25% glycerol and all the components of the well solution briefly before cryocooling. X-ray crystallographic data were collected on beamline id 14.2 at ESRF. All data were processed with DENZO and reduced with SCALEPACK (Otwinowski and Minor, 1997). Both structures were solved by molecular replacement (Vagin and Teplyakov, 1997) using the structure of the uncomplexed human enzyme (Gorman et al, 1997) (pdb code 1bix). ARP/WARP (Perrakis et al, 2001) was used for automatic model building and O50 for manual rebuilding. The structure was refined using both the CNS (Brunger et al, 1998) and REFMAC5 (Murshudov et al, 1997) packages with anisotropic B factors applied to the NApe structure only. The quality of all structures was assessed using both PROCHECK (Laskowski et al, 1993) and WHATCHECK (Hooft et al, 1996). Structures were superimposed using the lsq_exp and lsq_imp functions in O (Jones et al, 1991). Structural alignments were initially generated with CLUSTALW (Thompson et al, 1994), then manually adjusted using the programme JalView (Clamp et al, 2004) to match the structural alignment. Structure figures were generated using PyMol (DeLano Scientific). Bioinformatic analysis A database containing over 297 complete bacterial and eukaryotic genomes was searched to identify genes with similarity to NApe and NExo using NCBI BLAST (Altschul et al, 1997). Each gene identified as a possible paralogue was then used to search the N. meningitidis genome and matches were only accepted if the gene used for the original search was found in the N. meningitidis genome. All searches were performed with protein sequences. Organisms were identified which had both NApe and NExo paralogues and these genes were further analysed to identify which residue aligned with the His167 in NExo. Alignments were produced using ClustalW. The alignments were assisted by forcing matches to catalytically important residues. A total of 35 organisms were identified that clearly had both enzymes (Supplementary Table S2). These organisms were mapped onto a version of the tree of life and found to come from many but not all evolutionary families. Sequence processing and analysis were carried out using custom Perl scripts. Construction of bacterial strains and analysis of growth curves A 1771 bp fragment containing the open reading frame (orf) of NMB0399 was amplified by PCR from MC58 genomic DNA with primers NG489 and NG490 (Supplementary Table S3). The product was ligated into pCR TOPO2.1 (Invitrogen). The resulting plasmid was digested with SphI to remove a portion of the cassette encoding resistance to kanamycin, and then self-ligated to yield in pMW34. This plasmid was subjected to in vitro mutagenesis with Tn5 (Epicentre) and the sites of transposon insertion mapped by restriction enzyme analysis and sequencing. pMW34 contains Tn5 at nt 900 of the NMB0399 ORF. A 700 bp upstream fragment of NMB2082 was amplified with primers NG491 and NG492 and a 700 bp downstream region with primers NG493 and NG494 (Supplementary Table S3). The PCR products were ligated into pCR2.1TOPO. The upstream fragment was excised and ligated into the vector containing the downstream fragment. The gene encoding tetracycline resistance was removed from pCMT18 and inserted into between the up- and downstream fragments at the unique EcoRI site. N. meningitidis MC58 was transformed to kanamycin resistance by standard methods, and transformants were examined by PCR and Southern analysis to confirm that allelic replacement had occurred. For the analysis of bacterial growth, 10 ml of BHI broth was inoculated with bacteria to an of 0.15 and incubated at 37°C with shaking at 150 r.p.m. The optical density at 600 nm was measured at hourly intervals for up to 8 h. Assays for survival under oxidative stress Strains were grown overnight, harvested into PBS and the bacterial suspensions were adjusted to 1 × 108 colony-forming units (CFU)/ml and serial dilutions made. Each strain (10 μl, 103 CFU/ml) was then spread onto BHI agar containing either hydrogen peroxide (13 mM; Biochemika) or paraquat (0.075 mM; Sigma) or onto BHI alone. The number of CFU were counted and the survival of each strain on media containing paraquat or hydrogen peroxide was expressed as the proportion of survival on BHI alone. The assays were performed in triplicate on at least three independent occasions. Virulence assays To examine the effect loss of NExo and NApe on virulence, mixed litters of 5-day-old rats (Wistar) were inoculated with 1 × 107 CFU/ml N. meningitidis in PBS. Bacteria were grown overnight on solid media, resuspended in PBS and then enumerated by measuring the A260 of an aliquot of the suspension in lysis buffer (1% SDS/0.1 M NaOH). The virulence of the mutants was compared directly with MC58 in individual animals given a 1:1 ratio of wild-type to mutant bacteria. The number of mutant and wild-type bacteria recovered from the blood of animals 8 h later was established by plating to media with or without antibiotics. The competitive index (CI) was calculated as the (number of mutant/wild-type bacteria recovered from animals)/(number of mutant/wild-type bacteria in the inoculum). Supplementary Figure S1 Click here to view.(139K, pdf) Supplementary Figure S2 Click here to view.(287K, pdf) Supplementary Figure S3 Click here to view.(56K, pdf) Supplementary Table S1 Click here to view.(14K, pdf) Supplementary Table S2 Click here to view.(40K, pdf) Supplementary Table S3 Click here to view.(20K, pdf) Acknowledgments We thank the European Synchrotron Facility in Grenoble, France and the Synchrotron radiation facility, Daresbury, UK, for data collection and the MRC for financial support. Work in CMT's laboratory is supported by the Meningitis Research Foundation. We would also like to thank Mathieu Rappas, Valerie Pye and Ingrid Dreveny for assistance with X-ray crystallographic data collection and Gayle Bartlett and Derek Huntley of the ICL Bioinformatics service for assistance with the bioinformatics analysis. References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Nature. 1993 Apr 22; 362(6422):709-15.
[Nature. 1993]Mutat Res. 2003 Oct 29; 531(1-2):37-80.
[Mutat Res. 2003]Annu Rev Biochem. 1994; 63():915-48.
[Annu Rev Biochem. 1994]Mutat Res. 2003 Oct 29; 531(1-2):157-63.
[Mutat Res. 2003]J Bacteriol. 1976 May; 126(2):646-53.
[J Bacteriol. 1976]DNA Repair (Amst). 2004 Jan 5; 3(1):1-12.
[DNA Repair (Amst). 2004]Proc Natl Acad Sci U S A. 1996 Aug 20; 93(17):8919-23.
[Proc Natl Acad Sci U S A. 1996]Mutat Res. 1998 Oct 21; 409(1):17-29.
[Mutat Res. 1998]Cancer Res. 2001 Jul 15; 61(14):5552-7.
[Cancer Res. 2001]Microbiology. 2005 Feb; 151(Pt 2):557-67.
[Microbiology. 2005]J Bacteriol. 2006 Feb; 188(4):1295-300.
[J Bacteriol. 2006]Nat Rev Microbiol. 2006 Jan; 4(1):11-22.
[Nat Rev Microbiol. 2006]J Bacteriol. 2005 Apr; 187(8):2801-9.
[J Bacteriol. 2005]J Mol Biol. 1992 Aug 20; 226(4):1237-56.
[J Mol Biol. 1992]Eur J Biochem. 2003 Apr; 270(8):1838-49.
[Eur J Biochem. 2003]J Radiat Res (Tokyo). 1998 Jun; 39(2):137-44.
[J Radiat Res (Tokyo). 1998]Int J Radiat Biol. 2000 Jan; 76(1):67-75.
[Int J Radiat Biol. 2000]J Bacteriol. 1992 Oct; 174(20):6321-5.
[J Bacteriol. 1992]Annu Rev Biochem. 1994; 63():915-48.
[Annu Rev Biochem. 1994]Carcinogenesis. 1996 May; 17(5):1183-5.
[Carcinogenesis. 1996]Nature. 1995 Mar 23; 374(6520):381-6.
[Nature. 1995]EMBO J. 1997 Nov 3; 16(21):6548-58.
[EMBO J. 1997]Nature. 2000 Jan 27; 403(6768):451-6.
[Nature. 2000]Mol Microbiol. 2005 Feb; 55(3):853-61.
[Mol Microbiol. 2005]J Mol Biol. 1992 Aug 20; 226(4):1237-56.
[J Mol Biol. 1992]Eur J Biochem. 2003 Apr; 270(8):1838-49.
[Eur J Biochem. 2003]EMBO J. 1997 Nov 3; 16(21):6548-58.
[EMBO J. 1997]EMBO J. 1998 Dec 1; 17(23):7128-38.
[EMBO J. 1998]Nature. 2000 Jan 27; 403(6768):451-6.
[Nature. 2000]EMBO J. 1997 Nov 3; 16(21):6548-58.
[EMBO J. 1997]Nature. 2000 Jan 27; 403(6768):451-6.
[Nature. 2000]EMBO J. 1998 Dec 1; 17(23):7128-38.
[EMBO J. 1998]J Biol Chem. 1995 Jul 7; 270(27):16002-7.
[J Biol Chem. 1995]Nucleic Acids Res. 1997 Jun 15; 25(12):2495-500.
[Nucleic Acids Res. 1997]Nucleic Acids Res. 2006; 34(9):2508-15.
[Nucleic Acids Res. 2006]J Bacteriol. 1992 Dec; 174(23):7711-6.
[J Bacteriol. 1992]J Radiat Res (Tokyo). 1998 Jun; 39(2):137-44.
[J Radiat Res (Tokyo). 1998]J Biol Chem. 1999 Jan 1; 274(1):67-74.
[J Biol Chem. 1999]Prog Nucleic Acid Res Mol Biol. 2001; 68():315-47.
[Prog Nucleic Acid Res Mol Biol. 2001]J Bacteriol. 1991 Oct; 173(20):6489-98.
[J Bacteriol. 1991]PLoS Biol. 2005 Jul; 3(7):e255.
[PLoS Biol. 2005]Antimicrob Agents Chemother. 2006 Jan; 50(1):171-7.
[Antimicrob Agents Chemother. 2006]Infect Immun. 2006 Feb; 74(2):927-30.
[Infect Immun. 2006]J Infect Dis. 2004 Jul 1; 190(1):136-47.
[J Infect Dis. 2004]Infect Immun. 2003 Mar; 71(3):1604-7.
[Infect Immun. 2003]J Bacteriol. 1996 Jul; 178(14):4301-5.
[J Bacteriol. 1996]Nucleic Acids Res. 2003 Jan 1; 31(1):365-70.
[Nucleic Acids Res. 2003]Nucleic Acids Res. 1997 Sep 1; 25(17):3389-402.
[Nucleic Acids Res. 1997]Nucleic Acids Res. 2001 Sep 15; 29(18):3857-63.
[Nucleic Acids Res. 2001]EMBO J. 1997 Nov 3; 16(21):6548-58.
[EMBO J. 1997]Acta Crystallogr D Biol Crystallogr. 2001 Oct; 57(Pt 10):1445-50.
[Acta Crystallogr D Biol Crystallogr. 2001]Acta Crystallogr D Biol Crystallogr. 1998 Sep 1; 54(Pt 5):905-21.
[Acta Crystallogr D Biol Crystallogr. 1998]Acta Crystallogr D Biol Crystallogr. 1997 May 1; 53(Pt 3):240-55.
[Acta Crystallogr D Biol Crystallogr. 1997]Nature. 1996 May 23; 381(6580):272.
[Nature. 1996]Nucleic Acids Res. 1997 Sep 1; 25(17):3389-402.
[Nucleic Acids Res. 1997]